Buy CJC-1295 no DAC Peptide

Increased GH and IGF-1 Levels: Mod GRF 1-29 transiently stimulates growth hormone production by targeting the pituitary gland, leading to pulsatile increases in GH levels and secondary rises in IGF-1 [1]. Clinical trials, including studies on GHRH gene ablation and human consumption, demonstrated dose-dependent, sustained IGF-1 elevation with preserved growth hormone synthesis. These findings highlight its potential for supporting muscle strength, maintaining normal body weight, and optimizing peptide hormone function [2].

Improved Body Composition and Weight Loss: This peptide boosts natural growth hormone and increases IGF-1 levels. This pulsatile release helps build muscle, maintain lean body mass, and reduce fat [3].

Studies on animals, specifically GHRH-knockout mice, showed better body composition, including more lean tissue and less fat, after treatment [4]. More frequent dosing can even enhance these results. While human data is still limited, evidence suggests that increasing GH-IGF-1 activity can improve muscle mass and decrease both visceral and subcutaneous fat.

Better Sleep: Research suggests that modified GRF enhances GH and IGF-1 levels, which are linked to sleep regulation. Studies show that GH deficiency is associated with increased slow-wave sleep (SWS) intensity, likely due to overactive hypothalamic GHRH.

GH replacement therapy, including agents like CJC-1295, can normalize this by reducing excessive SWS intensity and improving sleep patterns. CJC-1295’s sustained GH release may support better sleep regulation, though its direct effects on sleep require further study [5].

Enhanced Cognitive Function: Research has shown that CJC-1295 without DAC may support cognitive function by enhancing growth hormone (GH) and IGF-1 levels, which are critical for brain health. Studies show that GHRH administration improves executive function and verbal memory in both healthy older adults and those with mild cognitive impairment (MCI) [6].

Additionally, GH has neuroprotective effects, promoting recovery in stroke models by aiding spatial memory and neuronal repair. These findings suggest CJC-1295’s potential to enhance cognitive performance and support brain health during aging and neurodegenerative conditions [7].

Cardioprotective: Research has shown that GRF 1-29 exhibits cardioprotective properties by activating cardiac repair mechanisms independent of the GH/IGF-1 axis. Studies show GHRH agonists like JI-38 improve cardiac function, reduce remodelling, and enhance anti-apoptotic gene expression after myocardial infarction (MI) [8].

Unlike IGF-1, which modulates inflammation and promotes anti-inflammatory macrophages, GHRH agonists directly stimulate cardiac precursor cell proliferation and repair, offering a promising therapeutic pathway for heart injury recovery [9].

Wound Healing and Tissue Repair: Research indicates that CJC-1295 no DAC supports wound healing and tissue repair by stimulating growth hormone (GH) release, which enhances IGF-1 production. IGF-1 promotes keratinocyte migration, wound epithelialization, and hyaluronan synthesis, aiding in challenging wound recovery, such as burns and diabetic ulcers [10].

Additionally, GH improves collagen deposition, angiogenesis, and granulation tissue formation while reducing inflammation, as seen in intestinal healing models. These combined effects highlight its potential in accelerating tissue repair [11].

Buy CJC-1295 no DAC Pre-Mixed Pen for in vitro testing and laboratory experimentation. There is the option to buy individual cartridges or a pen kit, which includes an injection pen, single use pen needle tips, and a single cartridge containing CJC-1295 no DAC pre-mixed with bacteriostatic water.